ABSTRACT
New endogenous antimicrobial peptides (AMPs) derived from chromogranin A (CgA) are secreted by nervous, endocrine and immune cells during stress. They display antimicrobial activities by lytic effects at micromolar range using a pore-forming mechanism against Gram-positive bacteria, filamentous fungi and yeasts. These AMPs can also penetrate quickly into neutrophils (without lytic effects), where, similarly to "cell penetrating peptides", they interact with cytoplasmic calmodulin, and induce calcium influx via Store Operated Channels therefore triggering neutrophils activation. Staphylococcus aureus and Salmonella enteritis are bacteria responsible for severe infections. We investigated here the effects of S. aureus and S. enteritis bacterial proteases on CgA-derived peptides and evaluated their antimicrobial activities. We showed that the Glu-C protease produced by S. aureus V8 induces the loss of the AMPs antibacterial activities and produces new antifungal peptides. In addition, four antimicrobial CGA-derived peptides (chromofungin, procatestatin, human/bovine catestatin) are degraded when treated with bacterial supernatants from S. aureus and S. enteritis, whereas, cateslytin, the short active form of catestatin, resists to this degradation. Finally, we demonstrate that several antimicrobial CgA-derived peptides are able to act synergistically with antibiotics against bacteria and fungi indicating their roles in innate defense.
Subject(s)
Antimicrobial Cationic Peptides/immunology , Chromogranin A/metabolism , Immunity, Innate , Amino Acid Sequence , Animals , Antimicrobial Cationic Peptides/chemistry , Antimicrobial Cationic Peptides/pharmacology , Cattle , Chromogranin A/chemistry , Chromogranin A/immunology , Chromogranin A/pharmacology , Fungi/drug effects , Host-Pathogen Interactions/immunology , Humans , Molecular Sequence Data , Neutrophils/immunology , Neutrophils/metabolism , Peptide Fragments/chemistry , Peptide Fragments/immunology , Peptide Fragments/pharmacology , Salmonella/drug effects , Serine Endopeptidases/metabolism , Staphylococcus aureus/drug effectsABSTRACT
Chromogranin A (CGA), produced by human and rat myocardium, generates several biologically active peptides processed at specific proteolytic cleavage sites. A highly conserved cleavage N-terminal site is the bond 64-65 that reproduces the native rat CGA sequence (rCGA1-64), corresponding to human N-terminal CGA-derived vasostatin-1. rCGA1-64 cardiotropic activity has been explored in rat cardiac preparations. In Langendorff perfused rat heart, rCGA1-64 (from 33 nM) induced negative inotropism and lusitropism as well as coronary dilation, counteracting isoproterenol (Iso) - and endothelin-1 (ET-1) -induced positive inotropic effects and ET-1-dependent coronary constriction. rCGA1-64 also depressed basal and Iso-induced contractility on rat papillary muscles, without affecting calcium transients on isolated ventricular cells. Structure-function analysis using three modified peptides on both rat heart and papillary muscles revealed the disulfide bridge requirement for the cardiotropic action. A decline in Iso intrinsic activity in the presence of the peptides indicates a noncompetitive antagonistic action. Experiments on rat isolated cardiomyocytes and bovine aortic endothelial cells indicate that the negative inotropism observed in rat papillary muscle is probably due to an endothelial phosphatidylinositol 3-kinase-dependent nitric oxide release, rather than to a direct action on cardiomyocytes. Taken together, our data strongly suggest that in the rat heart the homologous rCGA1-64 fragment exerts an autocrine/paracrine modulation of myocardial and coronary performance acting as stabilizer against intense excitatory stimuli.
Subject(s)
Chromogranin A/metabolism , Coronary Vessels/metabolism , Endothelial Cells/metabolism , Myocardial Contraction/physiology , Myocytes, Cardiac/metabolism , Nitric Oxide/metabolism , Papillary Muscles/metabolism , Vasodilation/physiology , Animals , Aorta/cytology , Aorta/metabolism , Autocrine Communication/drug effects , Autocrine Communication/physiology , Calcium/metabolism , Cardiotonic Agents/pharmacology , Cattle , Chromogranin A/pharmacology , Endothelial Cells/cytology , Endothelin-1/pharmacology , Humans , Isoproterenol/pharmacology , Male , Myocardial Contraction/drug effects , Myocytes, Cardiac/cytology , Papillary Muscles/cytology , Paracrine Communication/drug effects , Paracrine Communication/physiology , Phosphatidylinositol 3-Kinases/metabolism , Rats , Rats, Wistar , Structure-Activity Relationship , Vasodilation/drug effectsABSTRACT
Chromogranin A (CgA) belongs to the granin family of uniquely acidic secretory proteins co-stored and co-secreted with other hormones and peptides in elements of the diffuse neuroendocrine system. The granins arise from different genes and are characterized by numerous sites for post-translational cleavage into shorter peptides with postulated regulatory properties. This review is directed towards endocrine aspects of CgA and its biologically active peptides. There is ample evidence from in vitro studies of distinct effects and targets for three CgA-derived peptides, vasostatin-I, pancreastatin and catestatin. Endocrine regulations are indicated from in vivo studies, consistent with the postulated prohormone function of CgA for peptides with regulatory properties. Most of the effects fit into patterns of direct or indirect, inhibitory modulations of major functions, implicating CgA peptides in regulation of calcium and glucose metabolism, cardiovascular functions, gastrointestinal motility and nociception, tissue repair, inflammatory responses and as host defense peptides in the first phase of microbial invasions.
Subject(s)
Chromogranin A/physiology , Endocrine Glands/physiology , Animals , Calcium/metabolism , Carbohydrate Metabolism , Cardiovascular Physiological Phenomena , Chromogranin A/chemistry , Humans , Immunity, Innate , Inflammation/physiopathology , Models, Biological , Models, Molecular , Neoplasms/pathology , Neoplasms/physiopathology , Neuroendocrine Tumors/physiopathology , Neurosecretory Systems/physiology , Pancreatic Hormones/chemistry , Pancreatic Hormones/physiology , Peptide Fragments/chemistry , Peptide Fragments/physiology , Structure-Activity RelationshipABSTRACT
Catestatin (bCGA(344-364)), an endogenous peptide of bovine chromogranin A, was initially characterized for its effect on the inhibition of catecholamine release from chromaffin cells. Catestatin and its active domain (bCGA(344-358)) were identified in chromaffin cells and in secretion medium. The present study identified a potent antimicrobial activity of bCGA(344-358) in the lowmicromolar range against bacteria, fungi and yeasts, without showing any haemolytic activity. Confocal laser microscopy demonstrated penetration of the rhodaminated peptide into the cell membranes of fungi and yeasts and its intracellular accumulation. Time-lapse videomicroscopy showed arrest of fungal growth upon penetration of the labelled peptide into a fungal filament. We identified several catestatin-containing fragments in the stimulated secretion medium of human polymorphonuclear neutrophils, suggesting the N-terminal sequence of catestatin (bCGA(344-358)) (named cateslytin) as a novel component of innate immunity.
Subject(s)
Anti-Infective Agents/pharmacology , Catecholamines/chemistry , Chromogranins/chemistry , Chromogranins/pharmacology , Peptide Fragments/pharmacology , Amino Acid Sequence , Animals , Anti-Infective Agents/chemistry , Bacteria/drug effects , Cattle , Chromogranin A , Fungi/drug effects , Humans , Microbial Sensitivity Tests , Molecular Sequence Data , Peptide Fragments/chemistry , Time Factors , Yeasts/drug effectsABSTRACT
Secretory granules of chromaffin cells from the adrenal medulla store catecholamines and a variety of peptides that are secreted in the extracellular medium during exocytosis. Among these fragments, several natural peptides displaying antimicrobial activities at the micromolar range have been isolated and characterized. We have shown that these peptides, derived from the natural processing of chromogranins (CGs), proenkephalin-A (PEA) and free ubiquitin (Ub), are released into the circulation and display antibacterial and antifungal activities. In this review we focus on three naturally secreted antimicrobial peptides corresponding to CGA1-76 (vasostatin-I), the bisphosphorylated form of PEA209-237 (enkelytin) and Ub. In addition, the antimicrobial properties of the synthetic active domains of vasostatin-I (CGA47-66 or chromofungin) and Ub (Ub65-76 or ubifungin) are reported.
Subject(s)
Anti-Infective Agents , Chromogranins , Enkephalins , Immunity, Innate , Neuropeptides , Peptide Fragments , Ubiquitin , Amino Acid Sequence , Animals , Anti-Infective Agents/chemistry , Anti-Infective Agents/metabolism , Anti-Infective Agents/pharmacology , Bacteria/drug effects , Chromogranin A , Chromogranins/chemistry , Chromogranins/metabolism , Chromogranins/pharmacology , Enkephalins/chemistry , Enkephalins/metabolism , Enkephalins/pharmacology , Fungi/drug effects , Models, Molecular , Molecular Sequence Data , Neuropeptides/chemistry , Neuropeptides/metabolism , Neuropeptides/pharmacology , Peptide Fragments/chemistry , Peptide Fragments/metabolism , Peptide Fragments/pharmacology , Ubiquitin/chemistry , Ubiquitin/metabolism , Ubiquitin/pharmacologyABSTRACT
The secretory granules from adrenal medullary chromaffin cells contain a complex mixture of low-molecular mass constituents such as catecholamines, ascorbate, nucleotides, calcium, peptides, and several high-molecular mass water-soluble proteins including chromogranins and proenkephalin-A. These proteins are sequestered into secretory granules in which processing yields a large variety of peptides. These fragments are released into the extracellular space upon cell stimulation and are recovered in blood, lymph, cerebrospinal fluid, and synovial fluid. Some of them have biological activity on cells in an autocrine, paracrine, or endocrine fashion. In addition, we have shown that peptides with antimicrobial activity are present with the secretory chromaffin granules and demonstrated that they are released from stimulated chromaffin cells. We have shown that posttranslational modifications modulate the antimicrobial activities. For some peptides, using confocal laser microscopy, we have examined the interaction of the rhodaminated peptides with biological membranes. In addition, we have shown that chromofungin, the antifungal peptide corresponding to chromogranin A(47-66), can bind calmodulin in the presence of calcium and induce inhibition of calcineurin, a calmodulin-dependent enzyme. Because these antibacterial peptides are colocalized with catecholamines, they may be activated during stress, playing a role as a first protective barrier against bacterial infection, and thus act as factors of the innate immunity shortly after infection and before the induction and mobilization of an adaptative immune system.
Subject(s)
Anti-Infective Agents/pharmacology , Chromogranins/pharmacology , Enkephalins/pharmacology , Protein Precursors/pharmacology , Amino Acid Sequence , Animals , Chromogranin A , Humans , Mice , Molecular Sequence Data , Peptide Fragments/pharmacology , Rats , Sequence Alignment , Sequence Homology, Amino AcidSubject(s)
Cell Membrane/metabolism , Chromogranins/chemistry , Chromogranins/metabolism , Lipid Metabolism , Alternaria/metabolism , Animals , Aspergillus fumigatus/metabolism , Calcium-Binding Proteins/chemistry , Calcium-Binding Proteins/metabolism , Calreticulin , Cattle , Cells, Cultured , Chromogranin A , Neurospora crassa/metabolism , Peptide Fragments/chemistry , Peptide Fragments/metabolism , Phospholipids/metabolism , Protein Binding , Protein Structure, Tertiary , Ribonucleoproteins/chemistry , Ribonucleoproteins/metabolismABSTRACT
The antifungal peptide named chromofungin is the most active vasostatin-I-derived peptide, corresponding to the sequence 47-66 of chromogranin A. (1)H-NMR analysis revealed that it adopts a helical structure. The mechanism implicated in the interaction of chromofungin with fungi and yeast cells was studied by penetration of monolayers and confocal laser microscopy. Chromofungin is able to interact with the cell wall, to cross the plasma membrane, to accumulate in the microorganism, and to inhibit calcineurin activity.
Subject(s)
Chromogranins/chemistry , Chromogranins/pharmacology , Peptide Fragments/chemistry , Peptide Fragments/pharmacology , Peptides/chemistry , Alternaria/metabolism , Antifungal Agents/chemistry , Aspergillus fumigatus/metabolism , Calcineurin Inhibitors , Calcium-Binding Proteins/metabolism , Calreticulin , Candida albicans/metabolism , Cell Membrane/metabolism , Chromogranin A , Chromogranins/metabolism , Humans , Magnetic Resonance Spectroscopy , Peptide Fragments/metabolism , Peptides/pharmacology , Protein Structure, Tertiary , Ribonucleoproteins/metabolismABSTRACT
The ability of phosphatidylethanolamine-binding protein (PEBP) to bind membranes was tested by using small and large unilamellar vesicles and monolayers composed of l-alpha-1,2-dimyristoylphosphatidylcholine, l-alpha-1,2-dimyristoylphosphatidylglycerol and l-alpha-1,2-dimyristoylphosphatidylethanolamine. PEBP only bound to model membranes containing l-alpha-1,2-dimyristoylphosphatidylglycerol; the interaction was primarily due to electrostatic forces between the basic protein and the acidic phospholipids. Further experiments indicated that the interaction was not dependent on the length and unsaturation of the phospholipid acyl chains and was not modified by the presence of cholesterol in the membrane. PEBP affinity for negatively charged membranes is puzzling considering the previous identification of the protein as a phosphatidylethanolamine-binding protein, and suggests that the association of PEBP with phospholipid membranes is driven by a mechanism other than its binding to solubilized phosphatidylethanolamine. An explanation was suggested by its three-dimensional structure: a small cavity at the protein surface has been reported to be the binding site of the polar head of phosphatidylethanolamine, while the N-terminal and C-terminal parts of PEBP, exposed at the protein surface, appear to be involved in the interaction with membranes. To test this hypothesis, we synthesized the two PEBP terminal regions and tested them with model membranes in parallel with the whole protein. Both peptides displayed the same behaviour as whole PEBP, indicating that they could participate in the binding of PEBP to membranes. Our results strongly suggest that PEBP directly interacts with negatively charged membrane microdomains in living cells.
Subject(s)
Androgen-Binding Protein , Carrier Proteins/metabolism , Membranes, Artificial , Amino Acid Sequence , Animals , Carrier Proteins/chemistry , Cattle , Circular Dichroism , In Vitro Techniques , Models, Molecular , Molecular Sequence Data , Phospholipid Transfer Proteins , Spectrometry, FluorescenceABSTRACT
Vasostatin-I, the natural fragment of chromogranin A-(1-76), is a neuropeptide able to kill a large variety of fungi and yeast cells in the micromolar range. We have examined the antifungal properties of synthetic vasostatin-I-related peptides. The most active shortest peptide, named chromofungin, corresponds to the sequence Arg(47)-Leu(66). Extensive (1)H NMR analysis revealed that it adopts a helical structure. The biophysical mechanism implicated in the interaction of chromofungin with fungi and yeast cells was studied, showing the penetration of this peptide with different lipid monolayers. In order to examine thoroughly the antifungal activity of chromofungin, confocal laser microscopy was used to demonstrate the ability of the rhodamine-labeled peptide to interact with the fungal cell wall, to cross the plasma membrane, and to accumulate in Aspergillus fumigatus, Alternaria brassicola, and Candida albicans. Our present data reveal that chromofungin inhibits calcineurin activity, extending a previous observation that the N-terminal region of chromogranin A interacts with calmodulin in the presence of calcium. Therefore, the destabilization of fungal wall and plasma membrane, together with the possible intracellular inhibition of calmodulin-dependent enzymes, is likely to represent the mechanism by which vasostatin-I and chromofungin exert antifungal activity.
Subject(s)
Antifungal Agents/chemistry , Antifungal Agents/pharmacology , Chromogranins/chemistry , Chromogranins/pharmacology , Peptide Fragments/chemistry , Peptide Fragments/pharmacology , Amino Acid Sequence , Chromogranin A , Microbial Sensitivity Tests , Microscopy, Confocal , Models, Molecular , Molecular Sequence Data , Nuclear Magnetic Resonance, Biomolecular , Sequence Homology, Amino Acid , Structure-Activity RelationshipABSTRACT
A large variety of proenkephalin-A-derived peptides (PEAPs) are present in bovine adrenal medulla secretory granules that are cosecreted with catecholamines upon stimulation of chromaffin cells. In the present paper, after reverse phase high performance liquid chromatography of intragranular soluble material, PEAPs were immunodetected with antisera raised against specific proenkephalin-A (PEA) sequences (PEA63-70 and PEA224-237) and analyzed by matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry. Thirty PEAPs were characterized in addition to enkephalins and whole PEA, indicating that preferential proteolytic attacks occurred at both N- and C-terminal regions. A similar approach was used to characterize PEA-derived fragments exocytotically released into the extracellular space that showed five additional minor PEAPs. Among all these naturally generated peptides, enkelytin, the antibacterial bisphos- phorylated C-terminal peptide (PEA209-237), was predominantly generated, as shown by MALDI-TOF mass spectrometry analysis, which constituted an efficient method for its identification. Finally, the data on PEA intragranular and extracellular processing in adrenal medulla are discussed in regard to the known enzymatic processing mechanisms. We note the high conservation of the cleavage points in evolutionarily diverse organisms, highlighting an important biological function for the released PEAPs.
Subject(s)
Adrenal Medulla/metabolism , Chromaffin Cells/metabolism , Cytoplasmic Granules/metabolism , Enkephalins/metabolism , Protein Precursors/metabolism , Protein Processing, Post-Translational , Adrenal Medulla/cytology , Amino Acid Sequence , Animals , Cattle , Cells, Cultured , Cricetinae , Enkephalins/chemistry , Humans , Mesocricetus , Mice , Molecular Sequence Data , Peptide Fragments/chemistry , Protein Precursors/chemistry , Sequence Alignment , Sequence Homology, Amino Acid , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Xenopus laevisABSTRACT
The aim of the present study was to identify the protein that accounts for the cholesteryl ester transfer protein (CETP)-inhibitory activity that is specifically associated with human plasma high density lipoproteins (HDL). To this end, human HDL apolipoproteins were fractionated by preparative polyacrylamide gradient gel electrophoresis, and 30 distinct protein fractions with molecular masses ranging from 80 down to 2 kDa were tested for their ability to inhibit CETP activity. One single apolipoprotein fraction was able to completely inhibit CETP activity. The N-terminal sequence of the 6-kDa protein inhibitor matched the N-terminal sequence of human apoC-I, the inhibition was completely blocked by specific anti-apolipoprotein C-I antibodies, and mass spectrometry analysis confirmed the identity of the isolated inhibitor with full-length human apoC-I. Pure apoC-I was able to abolish CETP activity in a concentration-dependent manner and with a high efficiency (IC(50) = 100 nmol/liter). The inhibitory potency of total delipidated HDL apolipoproteins completely disappeared after a treatment with anti-apolipoprotein C-I antibodies, and the apoC-I deprivation of native plasma HDL by immunoaffinity chromatography produced a mean 43% rise in cholesteryl ester transfer rates. The main localization of apoC-I in HDL and not in low density lipoprotein in normolipidemic plasma provides further support for the specific property of HDL in inhibiting CETP activity.
Subject(s)
Apolipoproteins C/physiology , Carrier Proteins/antagonists & inhibitors , Cholesterol, HDL/physiology , Glycoproteins , Amino Acid Sequence , Apolipoprotein C-I , Carrier Proteins/metabolism , Cholesterol Ester Transfer Proteins , Cholesterol, HDL/chemistry , Cholesterol, HDL/metabolism , Cholesterol, LDL/physiology , Humans , Molecular Sequence Data , Protein BindingABSTRACT
Antibacterial peptides, found in both invertebrates and vertebrates, represent a potential innate defense mechanism against microbial infections. However, it is unknown whether this process occurs in humans during surgery. We looked for evidence of release of antibacterial peptides during coronary artery bypass grafting (CABG). We used immunological techniques and antibacterial assays combined with high-performance gel-permeation chromatography, reverse-phase HPLC, N-terminal sequencing and comparison with synthetic standards to characterize the peptide B/enkelytin. We show the presence of anionic antibacterial peptide, the peptide B/enkelytin which correspond to the C-terminal part of proenkephalin A, from the plasma of patients undergoing CABG. Our studies show that peptide B/enkelytin is initially present at low levels in plasma and is then released in increased amounts just after skin incision. Antibacterial assays confirmed that the peptides specifically target gram-positive bacteria. We also demonstrate that peptide B/enkelytin is metabolized in vivo to the opioid peptides methionine-enkephalin-Arg-Phe and methionine-enkephalin, peptides that we show have granulocyte chemotactic activity. These findings suggest that in humans, surgical incision leads to the release of antibacterial peptides. Furthermore, these antibacterial peptides can be metabolized into compounds that have immune-activating properties.
Subject(s)
Coronary Artery Bypass , Coronary Disease/immunology , Coronary Disease/microbiology , Enkephalins/blood , Peptide Fragments/blood , Amino Acid Sequence , Coronary Disease/surgery , Enkephalin, Methionine/blood , Enkephalin, Methionine/chemistry , Enkephalin, Methionine/isolation & purification , Enkephalins/chemistry , Enkephalins/isolation & purification , Escherichia coli , Escherichia coli Infections/blood , Escherichia coli Infections/immunology , Female , Gram-Positive Bacterial Infections/blood , Gram-Positive Bacterial Infections/immunology , Humans , Immunoblotting , Male , Micrococcus luteus , Middle Aged , Molecular Sequence Data , Peptide Fragments/chemistry , Peptide Fragments/isolation & purification , Protein Precursors/blood , Protein Precursors/chemistry , Protein Precursors/isolation & purification , Staphylococcal Infections/blood , Staphylococcal Infections/immunology , Staphylococcus aureus/immunologyABSTRACT
Previous studies showed that chromogranin A (CgA), a glycoprotein stored and co-released with various hormones by neuroendocrine cells and neurons, can modulate cell adhesion. We have investigated the structure-activity relationships of CgA using fibroblasts and coronary artery smooth muscle cells in adhesion assays. A recombinant CgA fragment 1-78 and a peptide 7-57 containing reduced and alkylated cysteines (Cys(17) and Cys(38)) induced cell adhesion after adsorption onto solid phases at 50-100 nm. Peptides lacking the disulfide loop region, including residues 47-68, 39-59, and 39-68, induced cell adhesion, either bound to solid phases at 200-400 nm or added to the liquid phase at 5-10 microm, whereas peptide 60-68 was inactive, suggesting that residues 47-57 are important for activity. The effect of CgA-(1-78) was blocked by anti-CgA antibodies against epitopes including residues Arg(53), His(54), and Leu(57). Substitutions of residues His(54), Gln(55), and Asn(56) with alanine decreased the cell adhesion activity of peptide 47-68. These results suggest that the region 47-57 (RILSILRHQNL) contains a cell adhesion site and that the disulfide bridge is not necessary for the proadhesive activity. The ability of soluble peptides to elicit proadhesive effects suggests an indirect mechanism. The high sequence conservation and accessibility to antibodies suggest that this region is important for the physiological role of CgA.
Subject(s)
Chromogranins/chemistry , Chromogranins/physiology , Fibroblasts , Muscle, Smooth, Vascular , Amino Acid Sequence , Binding Sites , Cell Adhesion , Cell Line , Chromogranin A , Humans , Molecular Sequence Data , Structure-Activity RelationshipABSTRACT
Lipopolysaccharides (LPS) injection into the coelomic fluid of the leech Theromyzon tessulatum stimulates release of proenkephalin A (PEA)-derived peptides as determined by immunoprecipitation and Western blot analyses. This release occurs in the first 15 min after LPS exposure and yields a 5.3-kDa peptide fragment corresponding to the C-terminal part of the precursor. This fragment is then cleaved to free an antibacterial peptide related to mammals arginine phenylalanine extended enkelytin: the peptide B. These PEA processing peptides were characterized using a combination of techniques including reversed-phase HPLC, microsequencing and mass spectrometry. The isolated invertebrate peptide B presents a high sequence homology with the bovine's and the same activity against Gram+bacteria. Titrations revealed the simultaneous appearance of Methionine-enkephalin (ME) and peptide B in invertebrates after stimulation by LPS (in a dose-dependent manner), surgical trauma or electrical stimulations to neural tissues of the mussel. Furthermore, peptide B processing in vitro yields Methionine-enkephalin arginine phenylalanine (MERF), which exhibits via the delta receptors, immunocyte excitatory properties, i.e., movement and conformational changes, but no antibacterial activity. We surmise that this unified response to the various stimuli is a survival strategy for organism by providing immediate antibacterial activity and immunocyte stimulation, thereby reducing any immune latency period needed for an adequate immune response.
Subject(s)
Enkephalins/metabolism , Leeches/immunology , Lipopolysaccharides/pharmacology , Peptide Fragments/metabolism , Protein Precursors/metabolism , Amino Acid Sequence , Animals , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/metabolism , Chromatography, High Pressure Liquid , Electrophoresis, Polyacrylamide Gel , Electroshock , Enkephalins/chemistry , Immunohistochemistry , Kinetics , Leeches/drug effects , Mass Spectrometry , Molecular Sequence Data , Peptide Fragments/chemistry , Protein Precursors/chemistrySubject(s)
Chromogranins/chemistry , Chromogranins/physiology , Amino Acid Sequence , Animals , Anti-Infective Agents/pharmacology , Antifungal Agents/pharmacology , Cattle , Chromogranin A , Chromogranins/genetics , Humans , Molecular Sequence Data , Protein Processing, Post-Translational , Proteins/physiology , Sequence Homology, Amino AcidSubject(s)
Anti-Infective Agents/isolation & purification , Antifungal Agents/isolation & purification , Chromogranins/chemistry , Enkephalins/chemistry , Protein Precursors/chemistry , Animals , Calcium-Binding Proteins/chemistry , Calcium-Binding Proteins/genetics , Calcium-Binding Proteins/physiology , Calreticulin , Cattle , Chromogranins/genetics , Chromogranins/physiology , Enkephalins/genetics , Enkephalins/isolation & purification , Enkephalins/physiology , Humans , Peptide Fragments/chemistry , Peptide Fragments/genetics , Peptide Fragments/isolation & purification , Peptide Fragments/physiology , Protein Precursors/genetics , Protein Precursors/physiology , Rats , Ribonucleoproteins/chemistry , Ribonucleoproteins/genetics , Ribonucleoproteins/physiologyABSTRACT
Vasostatin-1, the natural N-terminal 1-76 chromogranin A (CGA)-derived fragment in bovine sequence, has been purified from chromaffin secretory granules and identified by sequencing and matrix-assisted laser desorption time-of-flight mass spectrometry. This peptide, which displays antibacterial activity against Gram-positive bacteria at micromolar concentrations, is also able to kill a large variety of filamentous fungi and yeast cells in the 1-10 microM range. We have found that the C-terminal moiety of vasostatin-1 is essential for the antifungal activity, and shorter active peptides have been synthesized. In addition, from the comparison with the activity displayed by related peptides (human recombinant and rat synthetic fragments), we could determine that antibacterial and antifungal activities have different structural requirements. To assess for such activities in vivo, CGA and CGA-derived fragments were identified in secretory material released from human polymorphonuclear neutrophils upon stimulation. Vasostatin-1, which is stored in a large variety of cells (endocrine, neuroendocrine, and neurons) and which is liberated from stimulated chromaffin and immune cells upon stress, may represent a new component active in innate immunity.
Subject(s)
Anti-Infective Agents/pharmacology , Bacteria/drug effects , Chromogranins/pharmacology , Fungi/drug effects , Peptide Fragments/pharmacology , Amino Acid Sequence , Animals , Anti-Bacterial Agents , Cattle , Chromogranin A , Humans , Molecular Sequence Data , Neutrophils/metabolism , Rats , Recombinant Proteins/pharmacology , Structure-Activity RelationshipABSTRACT
Chromogranin A (CgA), a major protein of chromaffin granules, has been described as a potential marker for neuroendocrine tumours. Because of an extensive proteolysis which leads to a large heterogeneity of circulating fragments, its presence in blood has been assessed in most cases either by competitive immunoassays or with polyclonal antibodies. In the present study, 24 monoclonal antibodies were raised against native or recombinant human CgA. Their mapping with proteolytic peptides showed that they defined eight distinct epitopic groups which spanned two-thirds of the C-terminal part of human CgA. All monoclonal antibodies were tested by pair and compared with a reference radioimmunoassay (RIA) involving CGS06, one of the monoclonal antibodies against the 198-245 sequence. It appears that CgA C-terminal end seems to be highly affected by proteolysis and the association of C-terminal and median-part monoclonal antibodies is inadequate for total CgA assessment. Our new immunoradiometric assay involves two monoclonal antibodies, whose contiguous epitopes lie within the median 145-245 sequence. This assay allows a sensitive detection of total human CgA and correlates well with RIA because dibasic cleavage sites present in the central domain do not seem to be affected by degradation. It has been proved to be efficient in measuring CgA levels in patients with neuroendocrine tumours.
Subject(s)
Antibodies, Monoclonal/immunology , Chromogranins/metabolism , Immunoradiometric Assay/methods , Neuroendocrine Tumors/metabolism , Peptide Fragments/immunology , Amino Acid Sequence , Animals , Antibodies, Monoclonal/chemistry , Chromogranin A , Chromogranins/chemistry , Chromogranins/isolation & purification , Humans , Metalloendopeptidases/metabolism , Mice , Mice, Inbred BALB C , Recombinant Proteins/chemistry , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolismABSTRACT
Proenkephalin-A has been described to generate enkephalins, opoid peptides, and several derived peptides, which display various biological effects, including antinociception and immunological enhancement. Recently, we have isolated from bovine chromaffin granules a new antibacterial peptide, named enkelytin, which corresponds to the bisphosphorylated form of PEAP209-237 (Goumon, Y., Strub, J. M., Moniatte, M., Nullans, G., Poteur, L., Hubert, P., Van Dorsselaer, A., Aunis, D., and Metz-Boutigue, M. H. (1996) Eur. J. Biochem. 235, 516-525). In this paper, the three-dimensional solution structure of synthetic PEAP209-237 was investigated by NMR. These studies indicate that this peptide, which is unstructured in water, folds into an alpha-helical structure in trifluoroethanol/water (1/1). NMR data revealed two possible three-dimensional models of PEAP209-237. In both models, the proline residue Pro-227 induces a 90 degrees hinge between two alpha-helical segments (Ser-215 to Ser-221 and Glu-228 to Arg-232) leading to an overall L-shaped structure for the molecule. The negative charge of PEAP209-237 and the low amphipathy of the two alpha-helical segments imply new mechanisms to explain the antibacterial activity of enkelytin.